Skip to content
Search AI Powered

Latest Stories

Maker of OxyContin Now Has a Plan to Profit Off the Opioid Crisis They Had a Hand In Creating

Maker of OxyContin Now Has a Plan to Profit Off the Opioid Crisis They Had a Hand In Creating
PHILADELPHIA, PA - JANUARY 24: A man uses heroin under a bridge where he lives with other addicts in the Kensington section of Philadelphia which has become a hub for heroin use on January 24, 2018 in Philadelphia, Pennsylvania. Over 900 people died in 2016 in Philadelphia from opioid overdoses, a 30 percent increase from 2015. As the epidemic shows no signs of weakening, the number of fatalities this year is expected to surpass last year's numbers. Heroin use has doubled across the country since 2010, according to the DEA, part of an epidemic. Officials from Philadelphia recently announced that they want to become the first U.S. city to allow supervised drug injection sites as a way to combat the opioid epidemic. (Photo by Spencer Platt/Getty Images)

No shame.

In a twist completely apropos for 2018, Purdue Pharma, the maker of OxyContin, has received a patent for a medication designed to treat opioid addiction. Purdue Pharma is largely considered to be responsible for the current opioid epidemic.

The patent is not for an entirely new medication; rather, it is for a new and fast-acting form of an existing medication: buprenorphine.


One popular form of buprenorphine is sold under the name Suboxone. The medication acts as an opioid replacement. It works by controlling drug cravings and is used as an alternative for individuals hooked on painkillers or heroin. The current method of transmission for buprenorphine is a sublingual strip or tablet that dissolves under the tongue — something that can take up to 15 minutes to dissolve. The new form would be given in wafer form, dissolving in just a matter of seconds.

"While opioids have always been known to be useful in pain treatment, they also display an addictive potential. Thus, if opioids are taken by healthy human subjects with a drug-seeking behaviour they may lead to psychological as well as physical dependence,” the patent states.

OxyContin was originally created in 1995 by Purdue Pharma, and heavily marketed as a miracle painkiller. The marketing campaign was aggressive and eventually led to OxyContin becoming the most widely prescribed opioid medication. Even though sales have declined in recent years, the company still grossed over $2 billion in sales from the medication.

PHILADELPHIA, PA - JANUARY 24: A man uses heroin under a bridge where he lives with other addicts in the Kensington section of Philadelphia which has become a hub for heroin use on January 24, 2018 in Philadelphia, Pennsylvania. Over 900 people died in 2016 in Philadelphia from opioid overdoses, a 30 percent increase from 2015. As the epidemic shows no signs of weakening, the number of fatalities this year is expected to surpass last year's numbers. Heroin use has doubled across the country since 2010, according to the DEA, part of an epidemic. Officials from Philadelphia recently announced that they want to become the first U.S. city to allow supervised drug injection sites as a way to combat the opioid epidemic. (Photo by Spencer Platt/Getty Images)

In recent years, Purdue Pharma has been associated with numerous lawsuits related to the opioid epidemic. The Sackler family, which controls Purdue, was personally named in one of the lawsuits this past June. The Massachusetts Attorney General accused the family of a “deadly, deceptive scheme to sell opioids.”

For the most part, Purdue Pharma denies any culpability and deceptive practices. In a statement to CBS News, the company stated that all of their practices have been above board.

"Purdue is confident that its past marketing and sales of its prescription opioid medications have been consistent with the information contained in the FDA-approved label as the agency oversees the risks and benefits of prescription medications. Additionally, FDA has, and continues to, rigorously assess the science and medical practice around the appropriate treatment of chronic pain, while simultaneously working hard to ensure that our society suffers less from the scourges of prescription opioid abuse and addiction. Purdue is committed to working collaboratively with all those impacted by this public health crisis to help stem the tide of opioid-related deaths and addiction."

More than 72,000 people died from drug overdoses in 2017. That death count is higher than the yearly death tolls from HIV, car crashes or gun deaths. According to the CDC, 48,000 people died from opioid-related overdoses in the last year. Since 2013, 170,000 opioid-related deaths have occurred. The death toll, as caused by opioids, is staggering and epidemic. It’s tremendously ironic that a company largely credited for contributing to the addiction epidemic would now want to profit from its treatment.

As that death toll related to overdose and addiction continues to rise, something needs to be done on a systemic level. We need a solution based on new health initiatives, public health, and stigmatization, rather than allow the company which largely created the problem to continue to profit from it.

More from News

Melissa Calhoun
WKMG News 6 ClickOrlando/YouTube

Community Outraged After Florida Teacher Loses Job For Calling Student By Preferred Name

A Florida community is outraged after a veteran high school teacher was fired for calling a student by their preferred name rather than their legal name.

Melissa Calhoun had worked at Brevard County arts magnet school Satellite High School since 2019 and in the district for 12 years, but has been told her contract will not be renewed after the student's parent complained.

Keep ReadingShow less
Todd Lyons
Matt Stone/MediaNews Group/Boston/Getty Images

ICE Director Says He Wants To Run Deportations Like Amazon Prime, 'But With Human Beings'

While his boss at the Department of Homeland Security (DHS), Kristi Noem, came hot off the heels of cosplaying again and demonstrating how not to hold a gun, the acting Director of Immigration and Customs Enforcement (ICE) was modeling their human rights violations after online shopping.

Republican President Donald Trump's unconfirmed—nor congressionally vetted—acting Director of ICE, Todd Lyons, shared his dreams for the agency during the 2025 Border Security Expo, where private companies explored opportunities to profit from Trump’s mass deportations and rub elbows with Noem and Lyons.

Keep ReadingShow less
Screenshots of Vanessa Horabuena painting her Donald Trump portrait

Resurfaced Video Of MAGA Christian 'Worship Artist' Painting Portrait Of Trump Is Giving Major Cult Vibes

People are cringing after a video of MAGA artist Vanessa Horabuena speed-painting a portrait of President Donald Trump at the post-inauguration Liberty Ball resurfaced, highlighting the unsettling nature of what political scientists and casual observers have long described as Trump's cult of personality.

Horabuena raised more than $20,000 "to help cover the expenses of my team to attend this once in a lifetime event, the Liberty Ball just after the Inauguration where I will be painting live, 'Prayers For Our President,' to the song, 'The Blessing,' by Kari Jobe."

Keep ReadingShow less
Linda McMahon; A1 Steak Sauce
Win McNamee/Getty Images; Kevin Carter/Getty Images

Trump's Education Secretary Just Referred To 'AI' As 'A1'—And The Steak Sauce Seized The Moment

Education Secretary Linda McMahon was undoubtedly mistaken when she referred to artificial intelligence as "A1"—as in A1 Steak Sauce—while answering a question about the use of AI in schools, prompting the company to seize the moment with a trolling post.

McMahon slipped up during her appearance at the ASU+GSV Summit on Tuesday. While discussing the state of modern education, she brought up the role of AI in today's classrooms.

Keep ReadingShow less
Man holding a finger against his lips in a 'Shh!' gesture
Photo by Sander Sammy on Unsplash

People Anonymously Divulge The Secrets They Plan To Take To The Grave

As much as we might not want to, most of us have some secrets that we'd rather not tell.

But there are two kinds of people when it comes to long-term secrets: those who intend to take those secrets to the grave, no exceptions, and those who'd rather say, "Well, cat's outta the bag!"

Keep ReadingShow less